[Erowid Note: The dose described in this report is very high, potentially beyond Erowid's 'heavy' range, and could pose serious health risks or result in unwanted, extreme effects.
5-MeO-MiPT
Well-documented
Well-documented
Multiple authoritative sources agree on dosing and effects.
- 7 corroborating sources
- 3 ROAs with full dose ladders
- duration data present
- 27 combo interactions documented
- toxicity data (PsychonautWiki)
- classified Research-chemical
Well-documented
Multiple authoritative sources agree on dosing and effects.
- 7 corroborating sources
- 3 ROAs with full dose ladders
- duration data present
- 27 combo interactions documented
- toxicity data (PsychonautWiki)
- classified Research-chemical
Aliases: Moxy, 5meomipt, 5meo-mipt
Summary
5-Methoxy-N-methyl-N-isopropyltryptamine (also known as 5-MeO-MiPT and moxy) is a lesser-known psychedelic substance of the tryptamine class. 5-MeO-MiPT is chemically related to tryptamines like 5-MeO-DMT and 5-MeO-DiPT. It produces its psychoactive effects through activity at serotonin receptors in the brain.
Perspectives
“They do not follow the patterns or harmonies of traditional psychedelic visual effects- rather they are vague, disconnected, and extremely abstract. The headspace is unlike anything else, itβs a blank neutrality and a sense of suppression of the normal channels of psychedelic thought.”
“In 15 minutes I was already off of baseline, and by an hour it is unquestionably real. There is no visualization to music, but a general turned-on randiness. Dropping at an hour and a half, and out by three hours. Modest but real.”
Dose Information
| ROA | Light | Common | Strong | Heavy |
|---|---|---|---|---|
| Oral | 2-5mg | 5-10mg | 10-15mg | 15mg+ |
| Sublingual | 3-7mg | 7-15mg | 15-20mg | 20mg+ |
| Smoked | 5-10mg | 10-15mg | 15-20mg | 20mg+ |
Light
Common
Strong
Heavy
Sources· 1 of 3 ladders not fully identified
Oral
Dose ladder — dose.wikiSublingual
Dose ladder — Light, Common: not identified · Strong, Heavy: same as the Smoked row (dose.wiki, Drugs.Wiki, PsychonautWiki)Smoked
Dose ladder — dose.wiki, PsychonautWikiOnset, Duration & After-effects
| ROA | Onset | Comeup | Peak | Offset | Total |
|---|---|---|---|---|---|
| Oral | 19-40 min | 30-60 min | 2-3 hrs | 2-3 hrs | 5-8 hrs |
| Sublingual | 19-60 min | 30-60 min | 1-2 hrs | 1-2 hrs | 3-7 hrs |
| Smoked | <1-2 min | 1-4 min | 15-30 min | 1-2 hrs | 5-8 hrs |
Effect Profile
88 reportsScores (0–10) curated from multiple sources:
- Effect keyword matching from PsychonautWiki catalog
- Validated against 60 Erowid trip reports
- Weighted by importance: core (×3), major (×2), minor (×1)
Psychedelic
8.8
Intense+
9/10
Strong visuals, headspace, and auditory effects with strong body load
Visual Intensity
×3
10
internal hallucinations
colour enhancement
autonomous entities
drifting
tracers
colour shifting
+6 more
Headspace Depth
×3
10
conceptual thinking
thought connectivity
emotion enhancement
perspective alterations
personal bias suppression
time distortion
+1 more
Auditory Effects
×1
10
auditory distortion
auditory enhancement
auditory hallucinations
auditory hallucination
Body Load / Somatic Effects
×1
10
nausea
vasoconstriction
muscle tension
bodily pressures
increased heart rate
Empathogen
9.7
Extreme
10/10
Strong empathy, stimulation, sensory enhancement, and euphoria
Empathy / Social Openness
×3
10
empathy enhancement
empathy
empathy, love, and sociability enhancement
empathy, affection and sociability enhancement
Euphoria / Mood Elevation
×2
9
euphoria
emotion enhancement
Stimulation
×1
10
stimulation
wakefulness
restlessness
increased heart rate
Sensory Enhancement
×1
10
tactile enhancement
enhanced tactile sensation
spontaneous tactile sensations
colour enhancement
acuity enhancement
visual acuity enhancement
+1 more
Tolerance
Build-up
develops rapidly after a single use
Reset
7β14 days for baseline
Tolerance Decay
Half tolerance
7d
Baseline
~14d
Based on Erowidβs basics page indicating a short tolerance window with nearβbaseline by 5β7+ days; quantitative values are heuristic for planning gaps, not pharmacokinetic measurements. Crossβtolerance pattern inferred from general psychedelic class behavior (TripSit).
Cross-Tolerances
LSD/psilocybin/other serotonergic psychedelics
Effects
Aggregated from 60 single-substance Erowid and 28 Bluelight experience reports; 45 Erowid reports where another drug was taken too are left out
Each bar shows the share of analyzed reports whose text mentions that effect — a mention is not always a first-hand experience (fear of an effect or something witnessed can count). Mentions saying the effect did not happen are left out; that check reads keywords, so it can miss some. The shaded band on a bar, and the small range after its number, is the 95% interval: where the share could plausibly be with other reports of the same kind. Fewer reports, wider band. Tap or hover any number for details. The second value is the Bluelight extractor's per-effect confidence; a dash means the row is Erowid-derived, which has no confidence measurement.
Effect glossary — · full glossary
Positive Effects 63
52.3% (95% interval 42 to 62 percent)
84%
52.3% (95% interval 42 to 62 percent)
82%
47.7% (95% interval 38 to 58 percent)
88%
43.2% (95% interval 33 to 54 percent)
88%
35.3% (95% interval 26 to 46 percent)
80%
35.2% (95% interval 26 to 46 percent)
85%
32.1% (95% interval 18 to 51 percent)
84%
30.7% (95% interval 22 to 41 percent)
90%
29.5% (95% interval 21 to 40 percent)
86%
28.6% (95% interval 15 to 47 percent)
86%
28.6% (95% interval 15 to 47 percent)
84%
28.6% (95% interval 15 to 47 percent)
81%
Auditory Effects
27.3% (95% interval 19 to 37 percent)
81%
25.0% (95% interval 17 to 35 percent)
86%
25.0% (95% interval 13 to 43 percent)
82%
21.4% (95% interval 10 to 40 percent)
85%
21.4% (95% interval 10 to 40 percent)
85%
21.4% (95% interval 10 to 40 percent)
86%
21.4% (95% interval 10 to 40 percent)
78%
20.5% (95% interval 13 to 30 percent)
80%
Show 43 more positive effects
20.4% (95% interval 13 to 30 percent)
87%
18.3% (95% interval 11 to 30 percent)
–
17.9% (95% interval 8 to 36 percent)
80%
17.9% (95% interval 8 to 36 percent)
78%
17.9% (95% interval 8 to 36 percent)
81%
15.9% (95% interval 10 to 25 percent)
85%
14.3% (95% interval 6 to 32 percent)
78%
14.3% (95% interval 6 to 32 percent)
85%
10.7% (95% interval 4 to 27 percent)
83%
10.7% (95% interval 4 to 27 percent)
87%
10.7% (95% interval 4 to 27 percent)
82%
10.7% (95% interval 4 to 27 percent)
80%
7.1% (95% interval 2 to 23 percent)
78%
7.1% (95% interval 2 to 23 percent)
82%
7.1% (95% interval 2 to 23 percent)
80%
7.1% (95% interval 2 to 23 percent)
85%
7.1% (95% interval 2 to 23 percent)
88%
7.1% (95% interval 2 to 23 percent)
82%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
90%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
75%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
70%
3.6% (95% interval 1 to 18 percent)
90%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
95%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
65%
Adverse Effects 43
38.6% (95% interval 29 to 49 percent)
79%
35.7% (95% interval 21 to 54 percent)
82%
27.3% (95% interval 19 to 37 percent)
84%
21.6% (95% interval 14 to 31 percent)
80%
17.9% (95% interval 8 to 36 percent)
83%
17.0% (95% interval 11 to 26 percent)
80%
14.3% (95% interval 6 to 32 percent)
79%
14.3% (95% interval 6 to 32 percent)
79%
11.7% (95% interval 6 to 22 percent)
–
10.7% (95% interval 4 to 27 percent)
77%
10.7% (95% interval 4 to 27 percent)
82%
10.7% (95% interval 4 to 27 percent)
80%
7.1% (95% interval 2 to 23 percent)
78%
7.1% (95% interval 2 to 23 percent)
65%
7.1% (95% interval 2 to 23 percent)
80%
7.1% (95% interval 2 to 23 percent)
80%
7.1% (95% interval 2 to 23 percent)
88%
7.1% (95% interval 2 to 23 percent)
75%
7.1% (95% interval 2 to 23 percent)
90%
7.1% (95% interval 2 to 23 percent)
78%
Show 23 more adverse effects
6.8% (95% interval 3 to 14 percent)
80%
5.7% (95% interval 2 to 13 percent)
75%
5.0% (95% interval 2 to 14 percent)
–
3.6% (95% interval 1 to 18 percent)
70%
3.6% (95% interval 1 to 18 percent)
70%
3.6% (95% interval 1 to 18 percent)
65%
3.6% (95% interval 1 to 18 percent)
75%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
75%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
75%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
70%
3.6% (95% interval 1 to 18 percent)
90%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
95%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
75%
3.6% (95% interval 1 to 18 percent)
80%
3.6% (95% interval 1 to 18 percent)
85%
3.6% (95% interval 1 to 18 percent)
85%
Also reported in combinations. In the 45 5-MeO-MiPT reports where another drug was taken too, 3 (6.7%) mention hospital, emergency services or an overdose, 1 (2.2%) a seizure and 1 (2.2%) psychosis. In the 60 single-substance reports: 15.0%, 1.7% and 1.7%. These are not in the figures above: they cannot be put down to 5-MeO-MiPT alone, and a mention is not always something that happened to the writer.
Combinations
Cross-Check 5-MeO-MiPT with another substanceCommunity Trip Reports
Anecdotal first-person accounts from Reddit, Erowid, Bluelight, and Dose.wiki. Click a source to expand. Reports are harm-reduction context, not medical guidance. Tags summarise each author's own verdict — how reports are classified.
Erowid 8 reports 5 positive 3 cautionary visit
I've decide to share my first experience with 5-MeO-MiPT, it was an enjoyable one! I have a fairly decent amount of experience with psychedelics, having tried the following, most more than once: Weed, Hashish, Magic Mushrooms, DXM, MDMA, PMA, Meth, Codeine, Salvia Divinorum, AMT, 5-MeO-DiPT, Ketamine, 2C-E, 4-AcO-DMT,...
I wanted to start out writing this as describing who I am but you are not me and I am not you...I am I. I and I share a universal conscious that exists based on fear and love. I am accepted by nature and Love and distracted by man and Fear.
[This trip report is written from a multiple-identity perspective.] The following Greek letters have been changed to protect the innocent. This trip report is written by Omicron, with contributions by Zeta, Delta, Kappa, Lambda, Psi, and Rho. This was our third experience with taking 5-MeO-MiPT.
0:00/6:30PM: I just get off my shift volunteering for the burn and a friend of mine offers me a capsule. We were planning to take LSD and he tells me Moxy is the perfect thing to prime me for an acid trip. As he described Moxy it is supposed to feel like LSD mixed with MDMA.
Shulgin states that the oral dose for this drug is 4-6 mg. As I do with any drug that I haven't tried before, I weighed out a series of dosages on a precision scale, ranging from somewhat less than the recommended dose (3 mg) to approximately twice recommended dose (12 mg).
Life for the past month or so has been dull. I have had an ever-present sensation in the pit of my stomach of depression and anxiety which has been very difficult to shake and pretty much impossible to get rid of.
Before getting into this Article IΒd like to tell you about my history with psychoactive substances. I smoke cannabis on an almost daily basis for about 10 years now. Before that I regularly abused butane gas at very low age. I guess I was about 11 years old when this happened.
Dose.wiki 1 report 1 neutral visit
This would be my first foray into the 5-MeO-Tryptamines and I would later come to understand them as their own class of drug entirely. They are incomparable to other psychedelics for several reasons- The first is a lack of sensory stimulation and distortionsβ¦
Bluelight Reference Guide
Tryptamines The Big & Dandy 5-MeO-MiPT Thread - Part 2
The Big and Dandy 5-MeO-MiPT Thread (part 2) External Information Links Erowid 5-MeO-MiPT Vault Wikipedia 5-MeO-MiPT Entry TIHKAL 5-MeO-MiPT Entry Focused Discussion Sub-threads 5-MeO-MiPT + MDMA Combination Thread Previous Threads The Big & Dandy 5-MeO-MiPT Thread - Part 1
Read full thread on Bluelight βPiHKAL / TiHKAL
TiHKAL #40: 5-MeO-MIPT
“In 15 minutes I was already off of baseline, and by an hour it is unquestionably real. There is no visualization to music, but a general turned-on randiness. Dropping at an hour and a half, and out by three hours. Modest but real.”
5-MeO-MiPT's nerd page
Pharmacology, chemical data, effect profiles, and more
→
Helpful Links
Add missing routes to PsychonautWiki Journal
The PsychonautWiki Journal app already has 5-MeO-MiPT, but its built-in entry only covers Oral, Smoked. Here are the other routes we have data for. You can't edit a built-in substance, but you can add a Custom Unit for any of these routes to log it.
⬇ Download import file
Import this file as custom substances
and you get "5-MeO-MiPT (Substance Search)" with every
route's full dose ladder and timeline, no typing. Works on iOS and
Android (v15+); the format is confirmed by the app's
developer. The manual values below work for older
versions.
Custom Unit doses
- Sublingualcommon ~ 11 mg
Dose & duration (reference)
5-MeO-MiPT: routes the PsychonautWiki Journal app is missing Source: SubstanceSearch (substancesearch.com) Sublingual dose (mg): threshold 0.5-1 Β· light 3-7 Β· common 7-15 Β· strong 15-20 Β· heavy 20+ Sublingual duration: onset 0.32-1h Β· come-up 0.5-1h Β· peak 1-2h Β· offset 1-2h Β· total 3-7h Β· after-effects 1-3h Note: ranges are harm-reduction guidance, not a prescription. Start low, go slow, and test your substances.
Custom Units carry a single dose per route, so the full ranges live in the reference above. A route's suggested dose is the midpoint of its common range. Ranges are harm-reduction guidance, not a prescription.
Report an issue or suggest an edit
Spotted incorrect or dangerous information, have a correction, a new study, or a useful addition for 5-MeO-MiPT? Let us know. Reports are reviewed by moderators — this is not posted publicly.